Researchers commercializing new method to accelerate drug development
A new method for determining the crystal structures of organic salts – which make up 40% of all APIs – could “greatly speed up” the drug development process, say researchers.
A new method for determining the crystal structures of organic salts – which make up 40% of all APIs – could “greatly speed up” the drug development process, say researchers.
The global contract research organization (CRO) market is forecasted to grow 12% year-on-year through 2021 – led by IQVIA with 12.4% of the market share.
Responding to the need of ensuring information integrity, Scientist.com has launched DataSmart – which applies blockchain technology to protect data throughout the drug development process.
Codexis is setting up Porton Pharma Solutions with its biocatalyst technology as part of a strategic collaboration aimed at liberating potential cost reductions of up to 20%, says CEO.
The US FDA has issued Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd. a warning letter, in which it says the API maker admitted to deleting test data by accident.
CordenPharma has expanded its oligonucleotide active pharmaceutical ingredient manufacturing capacity in Colorado, US.